**Research Highlights**

(1)Electroacupuncture at the lower limbs and abdominal cavity is an effective means for fat weight loss and improvement of secretion function of adipose tissue.(2)Glucose-inhibited neurons are present in the lateral hypothalamic area, and can be regulated by electroacupuncture treatment at the lower limbs and abdominal cavity. This regulatory action may be one of the mechanisms underlying acupuncture treatment for simple obesity.(3)Electroacupuncture at different acupoints exerts various effects on the glucose-inhibited neurons in the lateral hypothalamic area.

INTRODUCTION {#sec1-1}
============

Simple obesity is a high-risk factor for hypertension, coronary heart disease, and type 2 diabetes mellitus. As such, the prevention and treatment of obesity has become a serious public health challenge. With the identification of numerous adipocyte factors including leptin, adipose-derived tumor necrosis factor, adiponectin, and resistin, adipose tissue is now well established as a highly active metabolic and endocrine organ\[[@ref1][@ref2]\]. Adipocyte factor secreted by adipose tissue also acts on the hypothalamic energy regulation center, and generates a connection between adipose tissue and the hypothalamus\[[@ref3]\], providing feedback regulation on the *in vivo* energy balance. Under normal conditions, the body fat content is stable. The body fat signal is present in the circulation, and when the body fat content changes, the signal stimulates the energy regulation center in the hypothalamus to adjust the body energy balance. Leptin is a key body fat signaling molecule\[[@ref4]\] that is secreted by adipose tissue, and can directly regulate *in vivo* energy balance and fat storage through the binding with the hypothalamic leptin receptor. Glucose-inhibited neurons act as a glucose detector to regulate feeding and maintain energy balance via alterations of neuronal discharge rate\[[@ref5]\]. Glucose-inhibited neurons, predominantly located in the lateral hypothalamic area (feeding center) and the lateral arcuate nucleus, modulate feeding behavior, and are closely correlated with obesity, diabetes, and other metabolic disorders. Glucose-inhibited neurons express neuropeptide Y, insulin, leptin, and other receptors\[[@ref6]\], and peripheral leptin and glucose signals converge in the feeding center\[[@ref7]\]. In addition, leptin and insulin control feeding regulation via the activity of glucose-inhibited neurons. Therefore, glucose-inhibited neurons may be important targets of leptin, in which the inhibitory effect on the feeding center is regulated by activity of glucose-inhibited neurons\[[@ref4]\].

The majority of obese patients present adipose tissue functional disorders\[[@ref8]\] and abnormal secretion of adipocyte factor. Electroacupuncture is regarded as an effective and safe means for treatment of simple obesity\[[@ref9][@ref10]\]. For example, electroacupuncture was reported to reduce food intake of the diet-induced obese rats\[[@ref11]\]. However, the inhibitory mechanism of electroacupuncture on feeding remains unclear. In this study, we examined adipocyte factors, feeding-related factors, and the activity of hypothalamic glucose-inhibited neurons to determine the influence of electroacupuncture at different acupoints on the adipose tissue-hypothalamic feeding pathways in obese rats, and to explore the weight reduction mechanism of electroacupuncture at lower limbs and abdominal cavity.

RESULTS {#sec1-2}
=======

Quantitative analysis of experimental animals {#sec2-1}
---------------------------------------------

Sprague-Dawley rats at 21 days of age were randomly divided into a normal diet group (*n* = 10) and a high fat diet group (*n* = 90). In the high fat diet group, 30 obesity rats were successfully established (33% success rate), which were then divided randomly into the model group (no electroacupuncture intervention), *Zusanli*/Inner Court group \[electroacupuncture at *Zusanli* (ST36)/Inner Court (ST44) acupoints at the left side\], and the *Tianshu/Tianshu* group \[electroacupuncture at bilateral *Tianshu* (ST25) acupoints\] (*n* = 10 per group).

Electroacupuncture effectively reduced the body weight of obese rats {#sec2-2}
--------------------------------------------------------------------

The body weight of experimental rats was increased after high fat diet (*P* \< 0.05). Electroacupuncture at *Zusanli*/Inner Court or *Tianshu*/*Tianshu* acupoints significantly reduced the body weight of obese rats (*P* \< 0.01) close to normal. There was no significant difference in body weight between the *Zusanli*/Inner Court group and the *Tianshu*/*Tianshu* group (*P* \> 0.05, [Table 1](#T1){ref-type="table"}).

###### 

Effect of electroacupuncture at various acupoints on body weight and fat-weight ratio of rats

![](NRR-8-809-g001)

Effect of electroacupuncture on adipocyte factors of obese rats {#sec2-3}
---------------------------------------------------------------

After rats were fed with high fat diet, the serum leptin, resistin, and tumor necrosis factor-α levels were increased, while adiponectin levels were decreased (*P* \< 0.05). Electroacupuncture at *Zusanli*/Inner Court or *Tianshu*/*Tianshu* acupoints decreased the serum leptin, resistin, and tumor necrosis factor-α levels, but increased adiponectin levels, in the obese rats (*P* \< 0.01). Acupuncture at *Zusanli*/Inner Court acupoints showed a stronger effect than that at bilateral *Tianshu* acupoints (*P* \< 0.05; [Figure 1](#F1){ref-type="fig"}).

![Effect of electroacupuncture on adipocyte factors of obese rats.\
Data are expressed as mean ± SD (*n* = 10 rats per group). Differences between the two groups were compared using independent samples *t*-test. ^a^*P* \< 0.05, *vs*. normal group; ^b^*P* \< 0.01, *vs*. model group; ^c^*P* \< 0.01, *vs*. **Zusanli**/Inner Court acupoint group.](NRR-8-809-g002){#F1}

Effect of electroacupuncture on serum feeding-related peptides in obesity rats {#sec2-4}
------------------------------------------------------------------------------

After rats were fed with a high fat diet, the serum neuropeptide Y level increased and cholecystokinin-8 level decreased (*P* \< 0.01). Electroacupuncture treatment decreased the neuropeptide Y level and increased cholecystokinin-8 level in obese rats (*P* \< 0.05; [Figure 2](#F2){ref-type="fig"}).

![Effect of electroacupuncture at various acupoints on the feeding related peptide in obese rats.\
Data are expressed as mean ± SD (*n* =10 rats per group). Comparison before and after treatment was performed using a paired sample *t*-test, and differences between the two groups were compared using an independent samples *t*-test. ^a^*P* \< 0.05, *vs*. normal group; ^b^*P* \< 0.01, *vs*. model group.](NRR-8-809-g003){#F2}

Effect of electroacupuncture on the discharge of glucose-inhibited neurons in lateral hypothalamus area of food deprived rats {#sec2-5}
-----------------------------------------------------------------------------------------------------------------------------

There were 13 glucose-inhibited neurons recorded in the normal group, with a discharge frequency of 4.01 ± 1.62 Hz, and 15 glucose-inhibited neurons recorded in the food deprivation group, with a discharge frequency of 7.36 ± 2.02 Hz. The discharge frequency of recorded neurons was higher in the food deprivation group than in the normal group (*P* \< 0.05), suggesting that the activity of glucose-inhibited neurons was altered by appetite hyperthyroidism pathology.

After electroacupuncture at the *Zusanli*/Inner Court acupoints, 31 glucose-inhibited neurons were completely recorded, 27 of which had a significantly altered discharge activity (27/31, 87%). Of these, electroacupuncture inhibited discharge activity in 22 neurons (22/27, 82%, *P* \< 0.01) and completely inhibited activity in six neurons. After electroacupuncture at *Tianshu*/*Tianshu* acupoints, 22 glucose-inhibited neurons were completely recorded, 16 of which had a significantly altered discharge activity (16/22, 73%). Of these, 11 neurons were excited by the electroacupuncture (11/16, 69%; [Table 2](#T2){ref-type="table"}, [Figure 3](#F3){ref-type="fig"}). These data suggest that electroacupuncture can alter the electrical activity of glucose-inhibited neurons. Furthermore, electroacupuncture at *Zusanli*/Inner Court acupoints exerts predominantly inhibitory effects, while electroacupuncture at *Tianshu*/*Tianshu* exerts predominantly excitatory effects role.

###### 

Effect of electroacupuncture at various acupoints on activity of glucose-inhibited neurons in the lateral hypothalamic area of food deprived rats \[number of neurons (%)\]

![](NRR-8-809-g004)

![Effect of electroacupuncture at *Zusanli* (ST36)/Inner Court (ST44) and *Tianshu* (ST25)/*Tianshu* acupoints on activity of glucose-inhibited neurons.\
(A) In the electroacupuncture at *Zusanli*/Inner Court point group, the discharge frequency of glucose-inhibited neurons decreased significantly after intravenous injection of glucose, and was not changed after saline injection, while glucose-inhibited neurons were inhibited by electroacupuncture at *Zusanli*/Inner Court points.\
(B) In the electroacupuncture at *Tianshu*/*Tianshu* acupoint group, glucose-inhibited neurons were excited by electroacupuncture at *Tianshu*.\
(C) After the experiment was complete, pontamine sky blue was applied to label the microelectrode recording sites. Arrow indicates pontamine sky blue exudation point (lateral hypothalamic area). The intervals are denoted by "-".](NRR-8-809-g005){#F3}

DISCUSSION {#sec1-3}
==========

Electroacupuncture stimulation can effectively reduce the body weight and body mass index of obese patients\[[@ref12][@ref13][@ref14][@ref15]\]. In addition, electroacupuncture can reduce body weight and food intake in obese rats, suggesting that central nuclei such as the lateral hypothalamic area, hypothalamic ventromedial nucleus, and arcuate nucleus, are likely to be involved in these regulatory mechanisms\[[@ref16][@ref17]\]. However, the specific neuronal types involved in these pathways remain unclear.

The hypothalamus plays a key role in controlling food intake, maintaining energy balance, and regulating neurohumor. Furthermore, the hypothalamus may integrate peripheral body fat signals such as leptin and insulin, as well as metabolic signals such as glucose and lipid\[[@ref18]\], to modulate feeding behavior. The lateral hypothalamic area is considered an important feeding center\[[@ref19]\], and more than 33% of neurons within this area are glucose-sensitive neurons\[[@ref20]\]. Thus, glucose-inhibited neurons may regulate feeding behavior caused by reduced circulating glucose levels. These actions of glucose-inhibited neurons are likely mediated by leptin\[[@ref18]\], which can inhibit feeding through inhibition of glucose-inhibited neurons. Signaling via adenosine monophosphate-activated protein kinase may play a key role in this pathway, as leptin inhibits hypothalamic adenosine monophosphate-activated protein kinase activity, while knockout of adenosine monophosphate-activated protein kinase in the hypothalamus reduces the effect of leptin on lowering food intake. There is also growing evidence to suggest that the excitability effect of hypoglycemia on glucose-inhibited neurons is similar to that of the adenosine monophosphate-activated protein kinase agonist 5-amino-imidazole-4-carboxamide riboside, which can be blocked by the adenosine monophosphate-activated protein kinase antagonist Compound C\[[@ref21]\]. Similarly, the inhibitory effects of leptin on glucose-inhibited neurons can be reversed by 5-amino-imidazole-4-carboxamide riboside.

Neuropeptide Y is the strongest pro-appetite peptide, and can be suppressed by leptin binding with the leptin receptor, thus inhibiting food intake and regulating energy metabolism. Hypothalamic neuropeptide Y neurons respond to extracellular glucose levels, suggesting that neuropeptide Y plays a crucial role in glucose sensing. The increase of extracellular glucose concentration may lead to the reduction in activation of agouti-related peptide/neuropeptide Y neurons\[[@ref22]\] and the release of neuropeptide Y. *In vivo* and *in vitro* experiments suggest that insulin-induced hypoglycemia can elevate the release of neuropeptide Y in the paraventricular nucleus of the hypothalamus in normal rats\[[@ref23]\]. Furthermore, 40% of neuropeptide Y neurons were reported to be glucose-inhibited neurons, and in the non-neuropeptide Y neurons, their inhibition in response to glucose was less than 5%\[[@ref22]\]. When sufficient energy is supplied, leptin reduces the activity of neuropeptide Y/glucose-inhibited neurons and food intake. In the fasting state, both leptin and glucose activate adenosine monophosphate-activated protein kinase in neuropeptide Y/glucose-inhibited neurons, leading to neuronal depolarization and increased neuropeptide Y release, increased food intake, reduced energy consumption, and maintenance of energy balance\[[@ref24]\]. Therefore, these data suggest that when starvation leads to reduced blood glucose levels, the excitability of glucose-inhibited neurons increases, triggering the release of neuropeptide Y and other pro-appetite substances, thus resulting in feeding behavior\[[@ref25]\].

Cholecystokinin-8 is an important satiety signal\[[@ref26]\], and functions to transfer satiety signals to the nucleus of solitary tract and the lateral hypothalamic area, as well as regulate feeding termination through activation of the gastric vagal nerve. There are two pathways involved in cholecystokinin-8 regulation of feeding: (1) gastric vagal nerve signals can directly transfer gastrointestinal hormones including cholecystokinin-8 to the glucose sensitive neurons in lateral hypothalamic area\[[@ref20][@ref27]\], and (2) leptin exerts intervention effects on cholecystokinin-8\[[@ref28]\], whereby leptin can improve the central satiety response to cholecystokinin, thus inhibiting feeding\[[@ref29][@ref30]\].

In the present study we found that electroacupuncture produced marked regulatory effects on body weight, fat-weight ratio, body fat signal leptin, and the feeding-related factors neuropeptide Y and cholecystokinin-8. Obese rats exhibited an abnormal increase of leptin suggestive of leptin resistance, while the increased levels of neuropeptide Y and decreased cholecystokinin-8 level indicate hyperthyroidism appetite and reduced perception to satiety signals in obese rats. Gong *et al*\[[@ref31]\] confirmed that electroacupuncture could improve leptin resistance in obese rats, indicating that acupuncture can regulate the levels of leptin, neuropeptide Y, and cholecystokinin-8. Acupuncture can also suppress hyperthyroidism appetite and simultaneously reduce perception to satiety signals, thus enhancing the satiety feeling. However, the central mechanism remains unclear. Thus, the aim of our study was to examine glucose-inhibited neurons in the lateral hypothalamic area to further explore the difference of electroacupuncture at various acupoints and its possible central mechanism.

In the fasting state, the activity of glucose-inhibited neurons is similar to that of the obesity rat model\[[@ref24]\]. Thus, we adopted experimental rats that had been fasted for 24 hours to simulate pathological models of hyperthyroidism appetite. We found that the discharge frequency of glucose-inhibited neurons increased in the food deprivation group, suggesting that the excitation of glucose-inhibited neurons may reflect hyperthyroidism appetite after food deprivation. The role of glucose-inhibited neurons in feeding has been previously demonstrated. However, there are limited data on the actions of electroacupuncture on glucose-inhibited neurons. Our experimental findings showed that electroacupuncture at *Zusanli*/Inner Court and *Tianshu*/*Tianshu* markedly altered the electrical activity of glucose-inhibited neurons in the lateral hypothalamic area. These data suggest that electroacupuncture at various acupoints can affect the activity of glucose-inhibited neurons and modulate feeding behavior. Thus, glucose-inhibited neurons may be a key target of electroacupuncture-mediated modulation of feeding behavior. In addition, the glucose-inhibited neurons were inhibited by electroacupuncture at the abdominal cavity and excited by electroacupuncture at the lower cavity. In summary, we suggest that the lower extremity acupoints may inhibit feeding behavior through leptin/glucose-inhibited neurons/neuropeptide Y neuron pathway, and can terminate feeding behavior by increasing cholecystokinin-8 levels and enhancing the satiety feeling. However, the mechanism associated with abdominal acupuncture requires further investigation. In addition, electroacupuncture plays a crucial role in modulating adipocyte factors. Endogenous tumor necrosis factor-α is the main source of adipose tissues\[[@ref32]\], and is closely related to lipid metabolism and glucose metabolism, and functions to promote lipolysis, increase energy expenditure, and reduce insulin sensitivity. Thus, tumor necrosis factor-α is considered one of the main factors leading to fat tissue insulin resistance\[[@ref33]\]. Adiponectin possesses anti-inflammatory and anti-insulin resistance effects\[[@ref34]\]. The levels of adiponectin are decreased in obese and type 2 diabetes patients, and the plasma concentration may be positively correlated with body mass index and fasting plasma glucose and triglyceride in the normal population. The biological role of resistin remains unclear, although animal trials demonstrate that resistin levels are elevated in diet-induced obese mice, and are positively related to insulin, leading to impaired glucose tolerance. Thus, it has been suggested to be involved in diet-induced obesity and insulin resistance-associated obesity\[[@ref35][@ref36]\]. A previous study confirmed that electroacupuncture can change abnormally secreted products in adipose tissue of obese rats\[[@ref37]\], while Sun *et al*\[[@ref38]\] reported that electroacupuncture improved lipid metabolism in experimental obese rats, with sex differences. In the present study, we also found significant differences in the regulation of adiponectin levels between electroacupuncture at *Zusanli*/Inner Court and *Tianshu*/*Tianshu* acupoints.

Overall, our data suggest that electroacupuncture at various acupoints may reduce body fat and act on the abnormal pathological link in fat-hypothalamic pathways by improving the abnormal secretion of adipose tissue, regulating body fat signals and feeding factors such as neuropeptide Y and cholecystokinin-8, and thereby adjusting abnormal feeding behaviors including hyperthyroidism appetite and reduced perception to satiety. In addition, the hypothalamic glucose-inhibited neurons can modulate energy balance.

MATERIALS AND METHODS {#sec1-4}
=====================

Design {#sec2-6}
------

A randomized, controlled, animal experiment.

Time and setting {#sec2-7}
----------------

Experiments were performed from March 2010 to November 2011 in the Experimental Animal Center of Nanjing University of Chinese Medicine, China.

Materials {#sec2-8}
---------

Sprague-Dawley male rats (specific pathogen free level) at neonatal 21 days (weaned), and 170 healthy male adult Wistar rats (specific pathogen free level) at 8--12 weeks old (250--350 g) were provided by Shanghai SLAC Experiment Animal Co., Ltd., China \[license No. SCXK (Hu) 2010-0010\]. All experimental animals were raised in the Experimental Animal Center of Nanjing University of Chinese Medicine, China. All experimental procedures were in accordance with the *Regulations for the Administration of Affairs Concerning Experimental Animals in Jiangsu Province*, China\[[@ref39]\].

Methods {#sec2-9}
-------

### Establishment of obese models {#sec3-1}

Sprague-Dawley rats were adapted to normal feed for 1 week, and then given a high fat diet containing 60% complete formula feed, 12% pork fat, 5% sucrose, 5% milk, 5% peanut, 10% egg, 1% sesame oil, and 2% salt (Suzhou Shuangshi Laboratory Animal Feed Science Co., Ltd., Suzhou, Jiangsu Province, China) for 3 months\[[@ref40]\]. Obesity was evaluated by an increase of 15% body weight higher than that of normal diet group (given complete formula feed; Suzhou Shuangshi Laboratory Animal Feed Science Co., Ltd.).

### Establishment of hyperthyroidism appetite models by food deprivation {#sec3-2}

Wistar rats were fasted for 24 hours prior to the experiment, with only access to sugar and water\[[@ref24]\].

### Electroacupuncture intervention at various acupoints {#sec3-3}

Acupuncture intervention at the *Zusanli* acupoint (5 mm below the capitulum fibulae, at lateral stifle joint) and the Inner Court acupoint (between the second and third metatarsus, posterior to the edge of toe web) was administered at a depth 0.5 mm on the left side. Bilateral *Tianshu* acupoints (5 mm lateral to the intersection between the upper 2/3 and the lower 1/3 in the line between xiphoid process and pubic symphysis upper border) was administered at a depth 0.5 mm. The acupuncture interventions were applied using a Han electroacupuncture therapeutic apparatus (LH~4~02A; Beijing Huawei Industrial Development Corporation, Beijing, China) at 2 Hz and 15 Hz alternating frequencies (intensity of 2 mA) for 15 minutes, once per day. The model group rats were only fixed, without acupuncture interventions. All experimental rats were weighed before each intervention, and the intervention was given for 6 successive days and allowed to rest for one day. During the 38-day observations, rats were treated or fixed for a total of 33 times, and allowing free access to normal diet.

### Calculation of fat-weight ratio {#sec3-4}

All experimental rats were fasted for 12 hours after the interventions were given, and their body weight was recorded (g). Under 20% urethane (0.8 g/kg) anesthesia, rats were euthanized and blood samples (3 mL) were collected by the retrobulbar capillary method. The abdominal cavity was then opened, and perirenal and epididymal fat (representative of visceral fat content) were harvested and weighed. The fat-weight ratio was calculated as: fat-weight ratio = visceral fat wet weight / weight after treatment × 100%.

### Enzyme linked immunosorbent assay for the measurement of serum leptin, neuropeptide Y, cholecystokinin-8, adiponectin, resistin, and tumor necrosis factor alpha levels {#sec3-5}

Serum leptin, neuropeptide Y, cholecystokinin-8, adiponectin, resistin, and tumor necrosis factor alpha levels were determined by enzyme linked immunosorbent assay\[[@ref37]\], according to the instructions of assay kit (Shanghai Touching Technology Co., Ltd., Shanghai, China).

### Discharge of glucose-inhibited neurons in lateral hypothalamus area {#sec3-6}

Wistar rats were anesthetized with an intraperitoneal injection of 20% urethane and 1.625% α-chloralose (65 mg/kg; Sigma, Milwaukee, WI, USA), and then received external jugular vein intubation and tracheal intubation. Animals were fixed onto a brain stereotaxic instrument (David Kopf Instruments, Tujunga, CA, USA), and according to the *Rat Brain in Stereotaxic Coordinates*\[[@ref41]\], brain tissue above the lateral hypothalamic area was exposed by craniotomy, and neuronal discharge was recorded using glass microelectrode (Nanjing Spring Teaching Experimental Instrument Factory, Nanjing, Jiangsu Province, China; containing 2% pontamine sky blue, Sigma, and 0.5 M sodium acetate; DC impedance 5--10 MΩ). External jugular vein injection of glucose (0.4 M) and saline was applied to identify glucose-inhibited neurons\[[@ref42][@ref43]\]; nerves exhibiting a response to glucose and no response to saline were considered to be the target nerves. After the discharge frequency was stable for 2 minutes, the baseline recordings were collected. The normal group and food deprivation group were recorded without interventions, while the *Zusanli*/Inner Court and *Tianshu*/*Tianshu* acupoint groups were given electroacupuncture during neuronal discharge recording. During the experiment, animal temperature was maintained at 37 ± 0.5°C using an electric heating board. After the end of the experiment, pontamine sky blue was dialyzed to the recording site at the electrode tip using the cathode current (10 μA, 10 minutes). Brain tissues were then fixed with 10% formalin solution, and sectioned using a freezing microtome. The recording sites beyond the lateral hypothalamic area were not included in the statistics. The neuronal discharge signals were amplified (A-M systems, Carlsborg, WA, USA) and monitored using an oscilloscope (DF4351A; Ningbo Zhongce Electronics, Ningbo, China), and then recorded with a physiological signal acquisition system (RM6240; Chengdu Instrument Factory, Chengdu, Sichuan Province, China). A time histogram before and after stimulation was plotted, and a change of more than 20% of baseline data in the discharge frequency before and after stimulation was used to indicate a neuronal response to the stimulus.

### Statistical analysis {#sec3-7}

Data are expressed as mean ± SD, and were analyzed using SPSS 17.0 software (SPSS, Chicago, IL, USA). Differences before and after treatment were compared using a paired sample *t*-test, the two groups were compared using an independent samples *t*-test, and comparison among groups was performed using analysis of variance. Neuronal discharge was analyzed by independent sample *t*-test, and count data were compared using the chi-square test. A *P* value less than 0.05 value was considered statistically significant.
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